Join us in this series on topics and trends taking place in Canada’s rapidly transforming life sciences ecosystem. Industry players, investors, and advisors on both sides of the Canada-U.S. border will want to join our interdisciplinary team for discussions on where the sector in Canada is headed—from product liability claim strategy and drug pricing to procurement, biometrics and more.
The future of product liability claims: is the MDL model coming to Canada?
As class action legislation changes across regions in Canada, there have been early signals that mass torts may be coming north as an alternative dispute model for product liability claims. Our panel will discuss where these developments may lead, issues related to simultaneous mass tort and class action litigation, and what impact it may all have on litigation strategy.
Ontario: This program is eligible for 60 Substantive minutes. New York: This program contains 1.0 Areas of Professional Practice credit. This course content is appropriate for transitional and non-transitional attorneys.